Overview of Lasilix Retard

Quick Facts

Property	Description
Active ingredient	Furosemide
Form	Hard gelatin capsule (Modified-release / Retard)
Pharmacological class	Loop Diuretic
General purpose	Management of fluid retention (Edema)
Origin	Synthetic compound

Lasilix Retard is a synthetic, monocomponent medicinal product whose active ingredient is Furosemide, a substance clinically recognized as a high-ceiling diuretic. This medicine is chemically a sulfonamide derivative and is categorized pharmacologically as a loop diuretic. The efficacy and safety profile of Furosemide are well-supported by decades of pharmacological studies.

What Does the “Retard” Formulation Mean?

The designation “Retard” signifies that this medicine is a modified-release or sustained-release dosage form, delivered as a hard gelatin capsule for oral administration. Unlike standard immediate-release forms of Furosemide, the Retard preparation is specifically engineered to release the active substance gradually over an extended period. This controlled delayed absorption is managed by the internal structure of the capsule, designed to avoid rapid peaks in concentration and provide a prolonged and steady effect throughout the day. This prolonged duration of action is a distinguishing characteristic. The Retard design aids in providing more consistent diuretic action over time, often making it suitable for patients requiring long-term, stable control of fluid balance.

What is the General Purpose of a Loop Diuretic?

The general purpose of a loop diuretic is to promote the excretion of excess salt and water from the body via the kidneys, thereby managing conditions of fluid overload. Furosemide achieves this by acting in the renal tubules, effectively blocking the reabsorption of sodium and chloride ions. This mechanism ensures that a significant volume of water is eliminated with the salts. By facilitating this potent reduction in overall fluid volume, the medicine contributes to the relief of edema (fluid retention) and assists in the management of high circulatory volume, which can be a factor in elevated blood pressure. As a diuretic, Furosemide is used to facilitate the loss of extra salt and water from the body.

Regulatory References

What side effects are possible with Lasilix Retard?

Possible Side Effects and Safety Information

Official regulatory documents emphasize that the most critical safety information for this medicine involves the potential for profound diuresis (increased urination) which can lead to severe dehydration and electrolyte depletion.

Adverse Reactions by Frequency

The following is a selection of documented adverse reactions, classified by their official reporting frequency:

Frequency	Examples of Reported Effects
Very Common	Electrolyte and fluid disturbances (including hypokalemia, hyponatremia)
Common	Hyponatremia, hypokalemia, hypochloremia, increased blood lipid levels, increased creatinine and urea levels
Uncommon	Thrombocytopenia (low platelet count), ototoxicity (hearing impairment), pruritus (itching), urticaria (hives)
Rare	Leukopenia, acute interstitial nephritis, vasculitis, severe hearing loss, pancreatitis, photosensitivity reactions
Very Rare	Agranulocytosis, aplastic anemia, hemolytic anemia, severe skin reactions (e.g., Stevens-Johnson syndrome)

Clinically Significant and Serious Risks

Serious adverse reactions include severe hypotension (low blood pressure), which can cause dizziness or syncope, and ototoxicity, particularly when the medicine is used at high doses or in conjunction with other ototoxic drugs. Thrombosis and vascular events are noted, especially in elderly patients due to the risk of hemoconcentration.

Safety Restrictions and Contraindications

The medicine is contraindicated and should not be used in patients with an absolute inability to pass urine (anuria), hepatic coma or pre-coma, severe electrolyte imbalances (e.g., severe hypokalemia, severe hyponatremia), or states of hypovolemia or dehydration. Use in premature infants carries a specific risk of nephrocalcinosis. The safety profile requires close monitoring of the patient's fluid and electrolyte status.

Overdose and Emergency Response

Overdose and when to seek help

This section describes the officially documented manifestations and required emergency actions for Lasilix Retard (Furosemide) overdose, based strictly on government regulatory documents.

Overdose Scope

Category	Official Regulatory Statement
Documented overdose presentations	Overdose with excessive amounts results in profound diuresis, leading to dehydration, blood volume reduction, and hypotension. Manifestations include significant electrolyte imbalance (e.g., hypokalemia and hypochloremic alkalosis), along with symptoms like thirst, weakness, and muscular cramps.
Physiological systems affected	The overdose profile includes effects on Fluid/Electrolyte Balance, the Circulatory System (circulatory collapse), and the Auditory System (reversible or irreversible hearing impairment and deafness (ototoxicity) with higher than recommended doses).
Population-specific overdose notes	Elderly patients are particularly at risk for vascular thrombosis and embolism secondary to fluid loss. In patients with hepatic cirrhosis, sudden alterations in fluid status may precipitate hepatic encephalopathy and coma.
When immediate medical help is required	Urgent medical attention must be sought for suspected overdosage, as excessive amounts of this potent diuretic can cause severe water and electrolyte depletion, potentially leading to circulatory collapse.

Resulting Overdose Structure

Official overdose statements:

Treatment is supportive, requiring frequent medical monitoring of serum electrolytes, carbon dioxide levels, and blood pressure.
Management involves the replacement of excessive fluid and electrolyte losses.
No specific antidote is known, and regulatory documents indicate that hemodialysis does not remove the drug.

Connection to the overall overdose profile: Regulatory documents define the Furosemide overdose profile based on its physiological consequence: a rapid and severe depletion of body fluid and electrolytes. This depletion establishes the conditions under which urgent medical care is mandatory, as it can escalate to life-threatening complications like circulatory collapse and vascular events, necessitating supportive management and rigorous monitoring.

Therapeutic Uses of Lasilix Retard

Lasilix Retard is commonly used for managing symptoms related to systemic imbalance and fluid retention, known as volume overload. It is applied in clinical settings where supportive management of significant fluid retention and its symptomatic impact is necessary. The medication is indicated for the treatment of edema associated with heart failure, liver cirrhosis, and renal disease.

Managing Severe Swelling and Chronic Congestion

This medication is commonly used to address the physical burden of peripheral and systemic swelling and internal congestion often seen in chronic conditions. It provides supportive relief by helping to ease discomfort and may assist with easing the impact of symptoms that interfere with daily functioning. The primary therapeutic areas involve conditions characterized by periods of heightened symptoms, such as Congestive Cardiac Failure, liver cirrhosis, and severe renal disease.

“Lasilix Retard is relevant for easing challenging symptoms of fluid retention and supporting stability across chronic conditions.”

Lasilix Retard also supports symptomatic relief in conditions where fluid collects in internal areas, such as the lungs and abdomen. This helps manage difficult symptoms like shortness of breath or dyspnea (alongside pulmonary congestion) and uncomfortable abdominal distention (ascites), offering support that helps patients cope more steadily with these distressing manifestations. As a prolonged-release formulation, it is relevant for long-term volume management, supporting consistent management of fluid fluctuations.

Quick Fact: Relief for Swelling and Breathlessness
Primary Symptom Domains: Symptoms related to physical discomfort (swelling, ascites) and symptoms linked to organ-specific functional stress (fluid congestion, dyspnea).

Eligibility and Restrictions for Use

Who Can and Cannot Use Lasilix Retard?

This section describes the officially documented population eligibility and restrictions for Lasilix Retard (Furosemide modified-release), based strictly on regulatory prescribing information.

Absolute Non-Eligibility (Contraindications)

Lasilix Retard is contraindicated and must not be used in specific patient groups or clinical states, including:

Patients with Anuria (inability to pass urine) unresponsive to treatment.
Individuals with a known Hypersensitivity (severe allergy) to Furosemide or its excipients.
Patients in a state of Hepatic Coma or pre-comatose hepatic encephalopathy.
Individuals with severe fluid or electrolyte imbalances, such as severe Hypovolemia (low blood volume) or severe Hypokalemia (low potassium).

Conditional Use and Restrictions

Use of the medicine requires special caution or conditional management in several populations:

Patients with Hepatic Cirrhosis and Ascites: Initial therapy is often recommended to be started in a hospital setting under strict observation.
Severe Renal Disease: The medicine must be discontinued if increasing azotemia (high nitrogen waste in blood) and oliguria (low urine output) occur.
Pregnancy and Lactation: Use during pregnancy is conditional and only allowed if the benefit justifies the potential risk. Breastfeeding is generally not recommended, as the medicine is excreted in breast milk.
Pediatric Use: While indicated for children, premature infants require mandatory renal function monitoring and renal ultrasonography due to the risk of kidney calcification.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile documents specific combinations and restrictions for Furosemide.

Interaction-Related Restrictions

Co-administration with Ethacrynic Acid or Aminoglycoside antibiotics (e.g., Gentamicin) is restricted due to a heightened and potentially irreversible risk of ototoxicity (hearing damage). The combination with Chloral Hydrate is not recommended, as it is associated with acute systemic reactions such as flushing and increased blood pressure. Furosemide reduces the renal clearance of Lithium, leading to a high risk of lithium toxicity.

Pharmacodynamic and Systemic Effects

Combining Furosemide with ACE inhibitors or Angiotensin II Receptor Blockers (ARBs) may lead to severe hypotension and potential deterioration in renal function. Medications that alter electrolytes, such as Corticosteroids or large amounts of Liquorice, increase the risk of hypokalaemia (low potassium).

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may antagonize the diuretic effect and increase the risk of nephrotoxicity.

Administration Timing and Specific Constraints

To prevent reduced absorption, administration of Sucralfate and Furosemide must be separated by a minimum of two hours.

In specific populations, co-administration with Risperidone in elderly patients with dementia is associated with a higher rate of death, as noted in regulatory labeling. The Furosemide effect may also be weakened and its ototoxicity potentiated in patients with Hypoproteinaemia.

Mechanism of Action

Lasilix Retard is a sustained-release formulation of furosemide, designed to provide prolonged pharmacological activity. Furosemide functions primarily as a loop diuretic by acting upon the renal system. Its mechanism of action begins at the cellular level by binding to and inhibiting the Na^+- K^+-2 Cl^- cotransporter ( NKCC2) protein.

This target protein is specifically located within the luminal membrane of the epithelial cells in the thick ascending limb of the loop of Henle in the kidney. Inhibition of the NKCC2 cotransporter prevents the active reabsorption of sodium ( Na^+), potassium ( K^+), and chloride ( Cl^-) ions from the renal filtrate back into the bloodstream. This inhibition results in an increased concentration of these ions delivered to the distal nephron. The consequent osmotic effect within the nephron lumen facilitates a substantial increase in the renal excretion of water and electrolytes, leading to physiological fluid mobilization. The sustained-release delivery system prolongs the duration of NKCC2 cotransporter antagonism.

Dosage and Administration Information

How to Use Lasilix Retard: Administration Guidelines

Lasilix Retard is a modified-release hard gelatin capsule containing the active substance Furosemide. The sustained-release design governs its specific pattern of use, which is focused on providing consistent therapeutic action over an extended period. The method of administration for this product is the oral route.

Administration Protocol

The modified-release formulation requires that the capsule be swallowed whole with water. This procedural constraint is essential to maintain the integrity of the Retard mechanism, which controls the gradual release of the active substance; consequently, the capsule must not be crushed, chewed, or opened.

The dosing frequency is typically once daily. To prevent the drug's diuretic action from interfering with nighttime sleep, it is routinely prescribed for administration in the morning, often taken before breakfast.

Standard Labeled Dosing

The standard adult treatment typically begins with an initial daily dose of 60 mg of the modified-release capsule. Should the initial dose require adjustment based on the clinical response, the daily amount may be increased up to a maximum daily dose of 120 mg. The use of this formulation is generally intended for the long-term management of fluid retention.

For older adults, dose selection is typically approached cautiously, often starting at the lower end of the dosing range, due to the potential for reduced kidney function. This reflects a general principle of using the lowest effective dose for this population.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Lasilix Retard

Evidence for Fluid Retention Associated with Heart Failure

The most extensive clinical research is relevant to the research base that explored fluid retention (edema) associated with heart conditions. Studies exploring this area include key Randomized Controlled Trials (RCTs) and larger meta-analyses that combine data from multiple clinical trials, alongside retrospective observational cohort studies. Research has examined outcomes related to systemic or functional imbalance, such as quantifying changes in fluid balance and monitoring shifts in body weight over short observation periods. The findings describe patterns observed in these studies, including measurements of fluid excretion and reports of how symptoms evolved in the observed populations.

Evidence for Fluid Retention Associated with Liver Disease

Research exploring whether this medication affects fluid retention associated with liver disease (cirrhosis) typically involves comparison studies and smaller Randomized Controlled Trials (RCTs). The research focused on outcomes related to physiological strain or stress, where studies monitored acute changes, such as the volume of urine output (diuresis) and corresponding immediate changes in body weight. The main research limitations in this area are that sample sizes were modest in many trials, and the follow-up durations were limited, focusing on acute fluid management.

Evidence for Fluid Retention Associated with Kidney Disease

The research base for fluid retention associated with kidney disease includes both structured Systematic Reviews of clinical trials and extensive Observational Cohort Studies. Studies explored the medication in relation to outcomes reflecting daily functioning or activity level, such as monitoring the overall urine volume and observing key markers of renal function. Observational data show patterns related to patient outcomes, including survival status and the requirement for renal replacement therapy (RRT). Data are still emerging regarding certain aspects of its use in kidney-related conditions, and findings were mixed in some meta-analyses exploring the research question of whether fluid management is associated with the progression of acute kidney injury.

What Research Gaps and Uncertainties Remain

The key limitation involves the Retard formulation itself, where comparative evidence is lacking for a direct long-term comparison against the standard oral form, meaning long-term effects are not fully established. While the broad evidence landscape was studied for fluid management, the evidence quality varies across studies, particularly in the renal and liver contexts where sample sizes were modest or the data were retrospective.

Frequently Asked Questions (FAQ)

Common questions about Lasilix Retard (FAQ)

Q: What is the main difference between Lasilix and Lasilix Retard?

A: The key difference lies in the way the medicine is released into the body. Lasilix Retard is a modified-release or sustained-release formulation, meaning the active ingredient is released gradually over an extended period. In contrast, standard Lasix (furosemide) is an immediate-release formulation.

Q: Does Lasilix Retard affect my blood pressure?

A: Yes, Furosemide has a hypotensive effect, meaning it is intended to lower blood pressure in certain conditions. However, official documentation also lists severe hypotension (low blood pressure) as a potential serious side effect.

Q: What happens if I miss a dose of Lasilix Retard?

A: Official product information describes a general protocol for missed doses. It typically advises against taking two doses together to make up for a missed dose. If a dose is missed, it should generally be taken as soon as it is remembered, unless it is almost time for the next scheduled dose.

Q: How long does it usually take for Lasilix Retard to start working?

A: The onset of diuresis (increased urination) following oral administration of standard furosemide is typically described as beginning within 1 hour. The Retard formulation is specifically engineered for a more gradual, prolonged effect throughout the day.

Q: Is Lasilix Retard used for weight loss?

A: According to official indications, Lasilix Retard is approved only for the treatment of edema, which is fluid retention associated with conditions like heart failure, liver disease, or kidney disease. It is not indicated for weight loss.

Q: What foods should I be careful about eating with Lasilix Retard?

A: Official patient information indicates a need to be mindful of salt (sodium) intake, as excessive salt consumption can prevent furosemide from working effectively. Due to the risk of low potassium, official guidance also notes that restricted salt intake may require potassium monitoring.

Q: Is Lasilix Retard safe for older adults to use?

A: Use in older adults is addressed in regulatory documents, with official guidance indicating caution is necessary due to the potential for reduced kidney function. Treatment often begins at the lower end of the dosing range, given the heightened risk of dehydration and thrombosis.

Q: Does Lasilix Retard have any long-term effects on the kidneys?

A: The drug is mainly removed from the body by the kidneys, and this removal is slower in kidney impairment. Reversible impairment of kidney function has been noted due to marked diuresis and dehydration, which are effects that should be closely managed.

Q: Why do doctors prescribe Lasilix Retard instead of a standard diuretic?

A: The 'Retard' design provides a prolonged and steady effect through controlled, delayed absorption. This sustained action is often considered beneficial for patients who require consistent, stable control of fluid balance over the long term.

Q: Can Lasilix Retard cause muscle cramps or weakness?

A: Muscle cramps, muscle pain, and weakness are listed in regulatory documents as potential symptoms. These effects can be a sign of electrolyte and fluid imbalances, such as low potassium (hypokalemia), which the drug may cause.

Q: Is there a risk of interaction between Lasilix Retard and herbal supplements?

A: Specific caution is detailed for products containing licorice in large amounts, as this can increase the risk of low potassium (hypokalemia). Generally, interactions with other herbal supplements are not specifically covered in regulatory labeling.

Q: Does Lasilix Retard need to be taken with food?

A: Regulatory documents state that standard immediate-release furosemide is generally recommended to be taken on an empty stomach. The Retard formulation is frequently prescribed to be taken in the morning before breakfast.

Q: Why is it important to have blood tests while using Lasilix Retard?

A: Periodic blood and urine tests are described in official documents as being important to monitor key values and detect unwanted effects. This includes checking serum electrolytes (like potassium and sodium), creatinine, and urea, which can be altered by the drug’s action.

Q: Can Lasilix Retard affect a person's blood sugar levels?

A: Yes, official documentation indicates that the medication may cause increases in blood glucose, known as hyperglycemia, and can affect glucose tolerance. Official guidance suggests that monitoring of blood and urine glucose may be required periodically for patients with diabetes.

Q: Is it safe to drive after taking Lasilix Retard?

A: Furosemide may cause side effects such as dizziness, lightheadedness, or confusion, especially when treatment begins or after a dose is changed. Official guidance indicates that caution is necessary regarding driving or operating machinery if these effects are experienced.

Q: Is it okay to drink alcohol while using Lasilix Retard?

A: Official information indicates that drinking alcohol may worsen the risk of orthostatic hypotension. This is a drop in blood pressure that occurs upon standing, which can lead to dizziness and fainting.

Q: What is the difference in how often Lasilix Retard is taken compared to immediate-release Lasilix?

A: Lasilix Retard is typically dosed once daily because its sustained-release design provides a long-lasting effect. In contrast, immediate-release furosemide is often dosed once or twice per day, depending on the patient's needs.

Q: Can Lasilix Retard make me feel tired or fatigued?

A: Weakness and lethargy (tiredness) are listed in regulatory documents as potential symptoms. These symptoms may occur due to the excessive fluid or electrolyte losses that can happen with the use of this medication.

Q: Is there a risk of developing gout while taking Lasilix Retard?

A: Yes, official adverse reaction lists include hyperuricemia (increased uric acid levels). Elevated uric acid levels are associated with an increased risk of developing gout.

Q: Does Lasilix Retard interact with commonly prescribed heart medications?

A: Yes, regulatory documents list specific interactions with heart medications such as ACE inhibitors or Angiotensin II Receptor Blockers (ARBs). Combining these may increase the risk of severe low blood pressure and kidney function deterioration.

Q: Is Lasilix Retard a commonly prescribed medicine?

A: Furosemide, the active ingredient in Lasilix Retard, is included on the World Health Organization's List of Essential Medicines. This designation indicates that it is considered one of the most effective and necessary medicines for a public health system.

Q: Are there any common reasons patients stop taking Lasilix Retard?

A: Therapy may need to be temporarily or permanently withdrawn if severe adverse reactions occur. It may also be stopped if fluid and electrolyte disturbances cannot be corrected or stabilized.

Q: How quickly does the effect of Lasilix Retard fade after stopping the medicine?

A: The elimination half-life of furosemide in patients with normal kidney function is typically around 1 hour. This means the active substance is cleared relatively quickly, though the Retard mechanism is designed to prolong the release period.

Q: Can Lasilix Retard cause changes in mood or confusion?

A: Restlessness, drowsiness, and lethargy (tiredness) are listed as potential symptoms of fluid and electrolyte imbalance caused by the medicine. Dizziness resulting from low blood pressure may also cause lightheadedness or feelings of confusion.

Q: Is it normal to feel thirsty while on Lasilix Retard?

A: Yes, thirst and dryness of mouth are explicitly listed in official patient information as symptoms to watch for. They are signs that a patient may be experiencing a fluid and electrolyte imbalance.

Q: Are there any common over-the-counter medicines that interact with Lasilix Retard?

A: Official interaction documents note that Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), a common over-the-counter pain reliever class, may weaken the diuretic effect. The medicine Sucralfate must be taken at least two hours apart to prevent reduced absorption.

Q: What are the typical signs that Lasilix Retard is working correctly?

A: The function is intended to increase the flow of urine (diuresis) to treat fluid retention (edema). Indications of success generally include an increase in fluid excretion and a reduction in edema.

Q: Is Lasilix Retard only for people with high blood pressure?

A: No. Regulatory documents state that the drug is indicated for the treatment of fluid retention (edema) associated with conditions like heart failure, kidney disease, or liver disease. It is also sometimes used to treat high blood pressure.

How should Lasilix Retard be stored and disposed of?

Official Storage and Disposal Requirements

Storage and handling of Lasilix Retard must strictly follow the conditions specified in official regulatory labeling to ensure product stability and safety.

Requirement Area	Official Conditions
Temperature and Environment	Store below 30^circmathrmC and protect from light and moisture.
Container and Integrity	Keep the medicine in the original container and do not freeze.
Child Safety	Keep out of the sight and reach of children.
Expiry Date	Do not use the medicine after the expiry date shown on the package.

For disposal, unused or expired Lasilix Retard must not be thrown away with household waste or disposed of via wastewater. The product must be discarded according to local requirements for pharmaceutical waste, often by returning it to a pharmacist or designated collection point.

Lasilix Retard